5-Methyl-3-isoxazolemethanesulfonyl chloride → 8-(5-Methyl-isoxazol-3-ylmethanesulfonyl)-2-(4-trifluoromethoxy-phenyl)-2,8-diaza-spiro[4.5]decan-1-one
반응식
C(O)(=O)C.[F:5][C:6]([F:26])([F:25])[O:7][C:8]1[CH:13]=[CH:12][C:11]([N:14]2[CH2:18][CH2:17][C:16]3([CH2:23][CH2:22][NH:21][CH2:20][CH2:19]3)[C:15]2=[O:24])=[CH:10][CH:9]=1.[CH3:27][C:28]1[O:32][N:31]=[C:30]([CH2:33][S:34](Cl)(=[O:36])=[O:35])[CH:29]=1>>[CH3:27][C:28]1[O:32][N:31]=[C:30]([CH2:33][S:34]([N:21]2[CH2:20][CH2:19][C:16]3([C:15](=[O:24])[N:14]([C:11]4[CH:12]=[CH:13][C:8]([O:7][C:6]([F:5])([F:25])[F:26])=[CH:9][CH:10]=4)[CH2:18][CH2:17]3)[CH2:23][CH2:22]2)(=[O:36])=[O:35])[CH:29]=1참가 물질
3
실험 절차
The title compound was prepared in analogy to example 180 step D from 2-(4-trifluoromethoxy-phenyl)-2,8-diaza-spiro[4.5]decan-1-one acetic acid salt (described in example 180 step C) and (5-Methyl-isoxazol-3-yl)-methanesulfonyl chloride. Light yellow solid. MS (ESI): 474.13 (MH+)
출처 및 근거
- ORD 기록
- ord-c3698cf4a6f0429e87dca2ca1d703575